Fate of patients with obstructive jaundice

Journal of Hospital Medicine

Volumn 3, Issue 2, 2008, Pages 117-123

  Björnsson, Einar ^a   Gustafsson, Jonas ^a   Borkman, Jakob ^a   Kilander, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Abdominal pain; Galltones; Jaundice carcinoma; Prognosis

Indexed keywords

BILIRUBIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CLINICAL FEATURE; COMMON BILE DUCT STONE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; SWEDEN; UNIVERSITY HOSPITAL; VATER PAPILLA CARCINOMA;

ABDOMINAL PAIN; AGED; AGED, 80 AND OVER; BILE DUCTS; CHOLEDOCHOLITHIASIS; COHORT STUDIES; CONSTRICTION, PATHOLOGIC; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HUMANS; JAUNDICE, OBSTRUCTIVE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 44249113589     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.272     Document Type: Article

References (25)

1. Whitehead MW, Hainsworth I, Kingham JG. The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut. 2001;48:409-413.
2. Björnsson E, Ismael S, Nejdet S, Kilander A. Severe jaundice in Sweden in the new millennium: causes, investigations, treatment and prognosis. Scand J Gastroenterol. 2003;38:86-94.
3. Lidofsky SD. Jaundice. In: O'Grady JG, Lake JR, Howdle PD, eds. Comprehensive Clinical Hepatology. London UK: Mosby; 2000:5.1-5.17.
4. Clain A. Examination of an adolescent or an adult patient with jaundice. Hamilton Baileys Demonstrations of Clinical Skills in Clinical Surgery. Bristol, UK; John Wright & Sons Ltd.; 1967:271-273.
5. Sherlock S, Dooley J. Jaundice. In: Sherlock S, Dooley J, eds. Diseases of the Liver and Biliary Tract. London, UK: Blackwell; 1993:1999-2013.
6. Burcharth F, Christiansen L, Efsen F, Nielbo N, Stage P. Percutaneous transhepatic cholangiography in diagnostic evaluation of 160 jaundiced patients. Results of an improved technic. Am J Surg. 1977; 133:559-561.
7. Pedrosa CS, Casanova R, Lezana AH, Fernandez MC. Computed tomography in obstructive jaundice. Part II: The cause of obstruction. Radiology. 1981;139:635-645.
8. Thomas MJ, Pellegrini CA, Way LW. Usefulness of diagnostic tests for biliary obstruction. Am J Surg. 1982; 144:102-108.
9. Honickman SP, Mueller PR, Wittenberg J, et al. Ultrasound in obstructive jaundice: prospective evaluation of site and cause. Radiology. 1983;147:511-515.
10. Di Bisceglie AM, Oettle GJ, Hodkinson HJ, Segal I. Obstructive jaundice in the South African black population. J Clin Gastroenterol. 1986;8:538-541.
11. Sharma MP, Ahuja V. Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective. Trop Gastroenterol. 1999;20:167-169.
12. Gillen P, Peel AL. Failure to improve survival by improved diagnostic techniques in patients with malignant jaundice. Br J Surg. 1986;73:631-633.
13. Little JM, Cunningham P. Obstructive jaundice in a referral unit: surgical practice and risk factors. Aust N Z J Surg. 1985;55:427-432.
14. Malchow-Moller A, Matzen P, Bjerregaard B, et al. Causes and characteristics of 500 consecutive cases of jaundice. Scand J Gastroenterol. 1981;16:1-6.
15. Cotton PB. Management of malignant bile duct obstruction. J Gastroenterol Hepatol. 1990;5(Suppl 1):63-77.
16. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200-1210.
17. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
18. Gudjonsson B. Critical look at resection for pancreatic cancer. Lancet. 1996;348:1676.
19. Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group. Eur J Cancer. 1998;34:2184-2190.
20. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363:1049-1057.
21. Taylor-Robinson SD, Toledano MB, Arora S, et al Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut. 2001;48:816-820.
22. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472-477.
23. Jarnagin WR, Shoup M. Surgical management of cholangio-carcinoma. Semin Liver Dis. 2004;24:189-199.
24. Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery. 2002;132:555-563.
25. Jarnagin WR, Burke E, Powers C, Fong Y, Blumgart LH. Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg. 1998; 175:453-460.